Literature DB >> 6270449

Receptor dysfunctions in human disease.

L H Block, W Tenschert, R Locher, W Siegenthaler, W Vetter.   

Abstract

The characterization of binding parameters of hormones and drugs to specific receptors at various human cell types have introduced an interesting approach for the evaluation of pathogenic mechanisms involved in endocrine and metabolic disorders. The dysregulation of cellular receptors in those disease include changes in receptor number, changes in binding affinity and production of antibodies against receptor molecules. It can be concluded from these observations that altered receptor physiology may be of important value for abnormalities in cellular recognition and control mechanisms which can be observed in neoplastic, inflammatory, immune and developmental diseases.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6270449     DOI: 10.1007/bf01698513

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  54 in total

Review 1.  Receptors for insulin, NSILA-s, and growth hormone: applications to disease states in man.

Authors:  J Roth; C R Kahn; M A Lesniak; P Gorden; P De Meyts; K Megyesi; D M Neville; J R Gavin; A H Soll; P Freychet; I D Goldfine; R S Bar; J A Archer
Journal:  Recent Prog Horm Res       Date:  1975

Review 2.  Peptide hormone receptors.

Authors:  K J Catt; M L Dufau
Journal:  Annu Rev Physiol       Date:  1977       Impact factor: 19.318

3.  ACTIVATION OF AN EPINEPHRINE-SENSITIVE LIPOLYTIC ACTIVITY FROM ADIPOSE TISSUE BY ADENOSINE 3',5'-PHOSPHATE.

Authors:  M A RIZACK
Journal:  J Biol Chem       Date:  1964-02       Impact factor: 5.157

Review 4.  Thyroid hormone receptors and responses.

Authors:  J D Baxter; N L Eberhardt; J W Apriletti; L K Johnson; R D Ivarie; B S Schachter; J A Morris; P H Seeburg; H M Goodman; K R Latham; J R Polansky; J A Martial
Journal:  Recent Prog Horm Res       Date:  1979

Review 5.  Nuclear receptors and the initiation of thyroid hormone action.

Authors:  J H Oppenheimer; H L Schwartz; M I Surks; D Koerner; W H Dillmann
Journal:  Recent Prog Horm Res       Date:  1976

6.  An adrenergic receptor mechanism for the control of cyclic 3'5' adenosine monophosphate synthesis in tissues.

Authors:  J R Turtle; D M Kipnis
Journal:  Biochem Biophys Res Commun       Date:  1967-09-07       Impact factor: 3.575

7.  Clinical implications of glucocorticoid receptors in human leukemia.

Authors:  M E Lippman; G K Yarbro; B G Leventhal
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

8.  Anti-insulin receptor antibodies and diabetes.

Authors:  W G Blackard; J H Anderson; F Mullinax
Journal:  Ann Intern Med       Date:  1977-05       Impact factor: 25.391

9.  Successful immunosuppressive therapy in insulin resistant diabetes caused by anti-insulin receptor autoantibodies.

Authors:  K Kawanishi; K Kawamura; Y Nishina; A Goto; S Okada
Journal:  J Clin Endocrinol Metab       Date:  1977-01       Impact factor: 5.958

10.  Biphasic adrenergic modulation of beta-adrenergic receptors in man. Agonist-induced early increment and late decrement in beta-adrenergic receptor number.

Authors:  J F Tohmeh; P E Cryer
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.